Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Anticoccidial Drugs Market

Anticoccidial Drugs Market Size

Report ID: GMI9889
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Anticoccidial Drugs Market Size

Anticoccidial Drugs Market size was valued at USD 183.1 million in 2023 and is anticipated to grow at a CAGR of 4.1% from 2024 and 2032. One of the key drivers is the increasing demand for poultry products, such as meat and eggs, due to the growing demand for protein-rich diets.

To get key market trends

Download Free Sample

This has led to a higher incidence of coccidiosis in poultry, necessitating the use of anticoccidial drugs for prevention and treatment. Additionally, the intensification of poultry farming practices, aimed at meeting the rising demand, has created a conducive environment for the spread of coccidiosis, further fueling the demand for these drugs. Furthermore, growing awareness among farmers about the economic benefits of using anticoccidial drugs, such as improved feed conversion rates and reduced mortality rates, is also contributing to market growth.

Anticoccidial drugs are pharmaceutical agents used to prevent and treat coccidiosis, a parasitic disease caused by protozoa of the genus Eimeria. This protozoon infects the intestinal tracts of animals, poultry, cattle, sheep, goats, swine, and companion animals. Coccidiosis can cause significant economic losses in the livestock industry due to decreased productivity, weight loss, and mortality.

Anticoccidial Drugs Market Report Attributes
Report Attribute	Details
Base Year:	2023
Anticoccidial Drugs Market Size in 2023:	USD 183.1 Million
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	4.1%
2024 – 2032 Value Projection:	USD 262.3 Million
Historical Data for:	2021 – 2023
No. of Pages:	218
Tables, Charts & Figures:	381
Segments covered:	Drug Class, Drug Action, Animal Type, Distribution Channel, and Region
Growth Drivers:	Increasing incidence of coccidiosis Growing livestock population Rising demand for animal protein
Pitfalls & Challenges:	High cost of drug development Stringent regulatory requirements

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global anticoccidial drugs market size was valued at USD 183.1 million in 2023 and is anticipated to grow at 4.1% CAGR during 2024-2032, driven by the increasing demand for poultry products, such as meat and eggs, due to the growing demand for protein-rich diets.

The synthetic compounds segment of the anticoccidial drugs industry held 62.1% share in 2023 and will expand rapidly through 2032, due to its high efficacy and broad spectrum of activity against various coccidia species.

North America anticoccidial drugs market is projected to witness 3.9% CAGR during 2024-2032, owing to substantial livestock and poultry industry, where coccidiosis is a prevalent concern.

Elanco Animal Health Incorporated, Huvepharma EOOD, Impextraco NV, Merck & Co., Inc, Phibro Animal Health Corporation, Vetoquinol SA, Virbac SA, and Zoetis Inc. among others.